Beschreibung

I am a former Vice President, Programs & Portfolio Office, with over 20 years of leadership experience in biotech and pharmaceutical environments.

Today, I operate as a Fractional Chief of Staff and Portfolio & Governance Executive, partnering with biotech CEOs, founders and Boards at critical inflection points.

I step in when:

• Portfolio complexity outpaces structure

• Capital discipline becomes decisive

• Execution credibility must be restored

My role is to bring executive alignment, governance clarity and milestone-driven prioritisation without adding bureaucracy.

I operate as an embedded executive partner, not an external consultant.

Sprachen

Französisch
Muttersprachlich oder zweisprachig
Englisch
Muttersprachlich oder zweisprachig
Deutsch
Konversationssicher
Spanisch
Konversationssicher

Arbeitsortpräferenzen

Vor Ort möglich

Bâle (bis zu 50 km)

enAbel Consulting
Founder & Fractional Executive
BIOTECHNOLOGIE
Juni 2025 - Heute (1 Jahr)
Bâle, Schweiz
Independent executive advisory platform supporting biotech leadership teams in governance structuring, portfolio prioritization and executive execution alignment.

Selected Mandate:
Synendos Therapeutics (CH)
Head of Development (Fractional Executive Mandate – 6 months)
• Acted as executive integrator between CEO, CMO, CCO and development teams
• Provided strategic development oversight during critical corporate phase
• Structured decision frameworks and cross-functional alignment mechanisms
• Reinforced portfolio focus and milestone discipline in capital-sensitive context
• Ensured executive visibility across development priorities and resource allocation
Fractional Leadership Biotechnology Program Leadership Portfolio Strategy Strategic Planning & Execution
MindMed (now Definium Therapeutics) - Biotech (US/CH)
VP, Head of Programs and Portfolio Office
BIOTECHNOLOGIE
September 2020 - Mai 2025 (4 Jahre und 8 Monate)
Zoug, Schweiz
Former executive leader responsible for portfolio governance, cross-functional execution alignment and milestone-driven delivery in a fast-scaling biotech environment.

Reported to Executive Leadership and worked closely with Board-level stakeholders during critical growth and capital allocation phases.

Scope of responsibility:
• Built and led the Programs & Portfolio Office
• Designed portfolio governance and decision frameworks
• Established milestone-driven prioritisation across clinical programs
• Strengthened executive-level risk visibility and escalation mechanisms
• Aligned cross-functional teams (Clinical, Regulatory, CMC, Finance) around strategic development milestones

Strategic impact:
• Increased execution predictability across pipeline programs
• Reduced decision latency at the executive level
• Improved portfolio transparency under capital pressure
• Enhanced cross-functional accountability and milestone discipline
Executive Leadership Portfolio Strategy Portfolio Governance Cross-functional Team Leadership Organizational Design
Creso Pharma – Biotech
Head of Operations
BIOTECHNOLOGIE
September 2017 - August 2020 (2 Jahre und 11 Monate)
Zug, Switzerland
Senior operating executive partnering directly with the CEO during a high-growth and corporate structuring phase.

Responsible for strengthening operational foundations, governance maturity and executive-level coordination across functions.

Scope of responsibility:
• Oversaw corporate operations across finance, administration, and external partnerships
• Contributed to corporate finance structuring and due diligence processes
• Supported M&A activities and cross-border growth initiatives
• Strengthened governance processes and executive reporting
• Drove operational alignment between leadership, external advisors, and investors

Strategic impact:
• Increased operational discipline and transparency
• Improved executive decision support during the expansion phase
• Enhanced cross-functional coordination and scalability
Executive Leadership Operational Strategy Corporate Governance Corporate Finance Mergers & Acquisitions